EUVIMEDEUVIMED entdecken
Multizentrische StudieEvaluationsstudieOpen Access · CC BY 4.0

Accuracy of nanopore-based targeted next-generation sequencing assay for detection of Mycobacterium tuberculosis and drug resistance from non-sputum specimens: a multicenter prospective study in China

Zeliang Yang iD, Zichun Ma, Zubi Liu, Peibo Li, Yuqin Liu, Long Cai iD, Biyi Su, Dan Li, Lele Wang, Lu Cui, Rui Shao, Dapeng Fan und 5 weitere

Journal of Clinical Microbiology · 2026

DOI: 10.1128/jcm.01433-25 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, 2026. Verfasst von Zeliang Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Key Technologies in Tuberculosis Prevention and Control, Department of Bacteriology and Immunology, Beijing Chest Hospital…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, High-Throughput Nucleotide Sequencing, Molecular Diagnostic Techniques, Tuberculosis. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Research Development Program of China, Beijing Tongzhou District Science and Technology Commission, Beijing Municipal Science & Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) remains the leading cause of mortality caused by a single infectious agent. Targeted next-generation sequencing (tNGS) has become a promising molecular method for TB diagnosis, but its accuracy and application for non-sputum specimens still remain unexplored. In this multicenter prospective lab-developed assay, 701 participants from five designated TB hospitals from different provinces in China were recruited. Non-sputum specimens were collected for tNGS, Xpert Mycobacterium tuberculosis (MTB)/RIF (Xpert), and culture tests. The diagnostic accuracy of tNGS for TB patients was evaluated compared with the microbiological reference standard (MRS). Phenotypic drug susceptibility tests (DSTs) were conducted using culture-positive isolates and employed to assess the accuracy of tNGS for detecting drug resistance. We found that the tNGS assay exhibited high diagnostic accuracy with sensitivity and specificity of 93.4% (95% CI, 91.5%–95.2%) and 93.2% (95% CI, 91.3%–95.0%) when utilizing MRS as the gold standard. The diagnostic performance of tNGS was robust regardless of specimen types and clinical symptoms. tNGS also showed a detection potential for other coinfecting respiratory pathogens. More than 90% of tNGS-positive individuals gained drug susceptibility results, which were mainly dependent on bacterial loads. Compared with phenotypical DSTs, tNGS had high sensitivities and specificities for the detection of rifampicin, isoniazid, streptomycin, ethambutol, and levofloxacin resistance. Our findings illustrated that tNGS assay is a rapid and highly sensitive test for TB diagnosis and simultaneous detection of drug resistance in non-sputum specimens. Its accuracy gain compared with conventional methods is most remarkable in TB patients with low bacterial loads. IMPORTANCE Tuberculosis (TB) diagnosis still remains challenging, especially in non-sputum patients. Nanopore-based targeted next-generation sequencing (tNGS) is a promising technology for the detection of TB cases and drug resistance, which has capacities to provide a panel of drug resistance profiles. The purpose of this study is to explore the diagnostic performance of tNGS for non-sputum specimens from five designated TB hospitals from different regions in China. Compared with the microbiological reference standard (MRS), tNGS exhibited high sensitivity and specificity, which are associated with bacterial loads in samples. Meanwhile, tNGS has capacities to detect coinfecting respiratory pathogens and produce drug-resistant profiles. Therefore, our findings suggested that tNGS is an alternative method for the diagnosis of non-sputum TB patients. CLINICAL TRIALS This study is registered with Chinese Clinical Trial Registry as ChiCTR2400088518 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisHigh-Throughput Nucleotide SequencingMolecular Diagnostic TechniquesTuberculosisDrug Resistance, BacterialHumansProspective StudiesChinaSensitivity and SpecificityFemaleAntitubercular AgentsMicrobial Sensitivity TestsMaleAdultMiddle AgedYoung AdultAged

Stichwörter der Autor:innen

diagnosisdrug susceptibilitynanopore-based targeted next-generation sequencingnon-sputum specimenstuberculosis

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Beijing Key Laboratory for Key Technologies in Tuberculosis Prevention and Control, Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor R…
  • Zhejiang Key Laboratory of Digital Technology in Medical Diagnostics, Dian Diagnostics Group Co., Ltd., Hangzhou, Zhejiang, China.
  • Department of Infectious Diseases, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of the Fifth Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China.
  • Infectious Disease Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
  • Department of Clinical Laboratory, Hangzhou Red Cross Hospital, Hangzhou, China.

ORCID-Profile: Zeliang Yang, Long Cai, Yaoju Tan, Liang Li, Yu Pang

Förderung

  • State Key Research Development Program of China
  • Beijing Tongzhou District Science and Technology Commission
  • Beijing Municipal Science & Technology Commission

Zitieren

APA

Yang, Z., Ma, Z., Liu, Z., Li, P., Liu, Y., Cai, L., Su, B., Li, D., Wang, L., Cui, L., Shao, R., Fan, D., Tan, Y., Shen, D., Shi, H., Li, L., & Pang, Y. (2026). Accuracy of nanopore-based targeted next-generation sequencing assay for detection of Mycobacterium tuberculosis and drug resistance from non-sputum specimens: a multicenter prospective study in China. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01433-25

Vancouver

Yang Z, Ma Z, Liu Z, Li P, Liu Y, Cai L, et al. Accuracy of nanopore-based targeted next-generation sequencing assay for detection of Mycobacterium tuberculosis and drug resistance from non-sputum specimens: a multicenter prospective study in China. Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.01433-25

BibTeX
@article{Yang2026,
  author = {Yang, Zeliang and Ma, Zichun and Liu, Zubi and Li, Peibo and Liu, Yuqin and Cai, Long and Su, Biyi and Li, Dan and Wang, Lele and Cui, Lu and Shao, Rui and Fan, Dapeng and Tan, Yaoju and Shen, Dan and Shi, Hong and Li, Liang and Pang, Yu},
  title = {Accuracy of nanopore-based targeted next-generation sequencing assay for detection of Mycobacterium tuberculosis and drug resistance from non-sputum specimens: a multicenter prospective study in China},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  doi = {10.1128/jcm.01433-25}
}
Kostenlos starten →